A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome-Reference-Cited by-同舟云学术

A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome

Published:2010-10-19 Issue:6 Volume:117 Page:1236-1244
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jabbour Elias,Kantarjian Hagop,Ravandi Farhad,Garcia-Manero Guillermo,Estrov Zeev,Verstovsek Srdan,O'Brien Susan,Faderl Stefan,Thomas Deborah A.,Wright John J.,Cortes Jorge

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25575/fullpdf

Reference29 articles.

1. Treatment of relapsed and refractory acute myeloid leukemia;Estey;Leukemia.,2000

2. The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature;Leopold;Leuk Lymphoma.,2002

3. New agents in acute myeloid leukemia and other myeloid disorders;Ravandi;Cancer.,2004

4. Azacitidine (AZA) treatment prolongs overall survival (OS) in higher-risk MDS patients compared with conventional cure regimens (CCR): results of the AZA-001 phase III study;Fenaux;Blood.,2007

5. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study;Kantarjian;Cancer.,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure;Circulation Research;2024-07-05

2. “Tip” the Scale of Cardiac Repair via Reducing Pathological Extracellular Vesicles;Circulation Research;2024-07-05

3. Virtual screening and biological evaluation to identify pharmaceuticals potentially causing hypertension and hypokalemia by inhibiting steroid 11β-hydroxylase;Toxicology and Applied Pharmacology;2023-09

4. Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?;Current Opinion in Oncology;2023-03-17

5. The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?;International Journal of Molecular Sciences;2021-11-08